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On 29 November 2016, the executive of the Council for International 
Organizations of Medical Science (CIOMS) approved the newly revised 
version of International Ethical Guidelines for Health-related Research 
Involving Humans.[1] This document combines and replaces the 2002 
CIOMS International Ethical Guidelines for Biomedical Research Involving 
Human Subjects and the 2009 ClOMS International Guidelines for Ethical 
Review of Epidemiological Studies. It was produced by an expert 
working group that met numerous times between September 2012 
and June 2016.
Public-health researchers have often complained that both 
international research-ethics guidelines such as the Declaration of 
Helsinki and the CIOMS documents, and most, if not all, national 
guidelines and regulations, do not take sufficient account of the 
differences between public-health research and other health-related 
research.[2] The primary aim of these documents is the protection of 
individual research participants and, to a lesser extent, communities, 
whereas public-health research prioritises health promotion and 
disease prevention among populations over protection of individuals.[3] 
When reviewed by research-ethics committees (RECs), public-health 
protocols are often judged by the same standards and criteria as 
clinical trials, even when these are clearly inappropriate. 
Do the 2016 CIOMS guidelines deal adequately with the ethical 
aspects of public-health research? In what follows I argue that 
although they are partially successful in this regard, they are silent 
on some important public-health research issues, and problematic 
on others. 
Ethical issues on which the guidelines are 
especially useful
In some respects the 2016 document represents a significant advance 
over previous versions, and contains much useful information for 
public-health researchers. The following guidelines are particularly 
applicable to public-health research:
• Guideline 1, ‘Scientific and social value and respect for rights’, 
states that ‘all research is [to be] carried out in ways that 
uphold human rights, and respect, protect and are fair to study 
participants and the communities in which the research is 
conducted.’ There was no guideline on social value in previous 
versions, and the commentary on this guideline makes explicit 
mention of public health in relation to social value.
• The new guideline 7, ‘Community engagement’, does not mention 
public health as such, but is clearly applicable. The commentary 
provides a broad definition of ‘community’ that ‘consists not only 
of people living in the geographical area where research is to 
be carried out; it also comprises different sectors of society that 
have a stake in the proposed research, as well as subpopulations 
from which research participants will be recruited’. However, the 
guideline and commentary do not include community approval of 
or consent to research as an aspect of engagement, and they leave 
important questions unasked (see below).
• The new guideline 20, ‘Research in disasters and disease outbreaks’, 
is clearly relevant to public-health research. It reflects the great 
amount of ethical analysis of responses to recent pandemics of 
severe acute respiratory syndrome (SARS), avian influenza and 
Ebola[4,5] and, to a lesser extent, of earthquakes and weather-related 
disasters, although there is no mention of wars.
• Another new guideline, 21, ‘Cluster randomised trials’, is likewise of 
major concern to public-health research, since those randomised 
are ‘groups of individuals (clusters), communities, hospitals, or 
units of a health facility’. However, the guideline’s primary focus, 
as throughout the entire document, is on individual members of 
these groups, whether patients or healthcare workers.
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• Guideline 24, ‘Public accountability for health-related research’, 
calls on researchers to share their data, thereby echoing previous 
demands from those engaged in public-health research.[6]
Ethical issues on which the guidelines are 
silent 
What public-health research is
Whereas medical research has well-established methodologies, such 
as clinical trials, that differentiate it from medical practice, it is 
sometimes difficult to determine whether a public-health activity is 
research or something else, such as programme evaluation or quality 
improvement, and the guidelines do not address this issue. 
Health inequities
Although the first guideline is entitled ‘Scientific and social value and 
respect for rights’, neither the guideline nor its commentary mentions 
health inequities, a major concern of public health.[7]
Novel research methodologies
The guidelines do not mention the evaluation of research 
methodologies that are unfamiliar to members of RECs, such as those 
employed by some public-health researchers.[8,9] The commentary 
on guideline 23 requires RECs to ‘either carry out a proper scientific 
review, verify that a competent expert body has determined the 
research to be scientifically sound, or consult with competent experts 
to ensure that the research design and methods are appropriate’. 
However, the guideline provides no criteria for making such a 
judgement.  
Ethical issues on which the guidelines are 
problematic 
To what extent are the guidelines applicable to 
public-health research? 
On the one hand, the preface states that ‘the current scope is confined 
to the classic activities that fall under health-related research with 
humans, such as observational research, clinical trials, biobanking 
and epidemiological studies.’ Although this list may not be intended 
to be exhaustive, it is unclear whether all public-health research is 
included within ‘classic activities’. Just below, however, the preamble 
claims that ‘the ethical principles set forth in these guidelines should 
be upheld in the ethical review of research protocols. The ethical 
principles are regarded as universal.’ (Unlike the 2002 version of the 
guidelines, this one does not name its ethical principles, nor is there 
any definition or discussion of ethics.) This statement, and others 
found throughout the document, suggest that all health-related 
research activities, including public-health research, are subject to 
the same principles and procedures for ethics review. 
When is REC approval required? 
Guidelines 10 and 23, which deal with this matter, are at best unclear 
and arguably inconsistent, especially with regard to public-health 
research. No. 23 states: ‘All proposals to conduct health-related 
research involving humans must be submitted to a REC to determine 
whether they qualify for ethical review and to assess their ethical 
acceptability, unless they qualify for an exemption from ethical 
review (which may depend upon the nature of the research and upon 
applicable law or regulations)’. The commentary on this guideline 
includes the following paragraph on exemptions from review: ‘Some 
studies may be exempt from review. For example, when publicly 
available data are analysed or the data for the study are generated 
by observation of public behaviour, and data that could identify 
individual persons or groups are anonymized or coded, the study may 
be exempt. Health-systems research may be exempted from review 
if public officials are interviewed in their official capacity on issues 
in the public domain’. It is unclear whether the researcher has the 
authority to decide if a study qualifies for exemption from REC review 
or whether this is the prerogative of the REC. 
A similar problem is found in guideline 10, ‘Modifications and 
waivers of informed consent’, which states unequivocally: ‘Researchers 
must not initiate research involving humans without obtaining 
each participant’s individual informed consent or that of a legally 
authorised representative, unless researchers have obtained explicit 
approval to do so from a research ethics committee’. However, the 
commentary on this guideline states: ‘When a study is performed 
under a public-health mandate or by public-health authorities, such 
as disease surveillance, normally neither ethical review nor a waiver 
of consent is needed because the activity is mandated by law’. The 
commentary compounds this ambiguity where it says: ‘Although 
the extent and limits of data collection are determined by law, 
researchers must still consider whether, in a given case, it is ethical to 
use their authority to access personal data for research purposes’. No 
criteria are given for making this determination.
Consent
The primary focus of public-health research is human populations 
and the institutions that provide healthcare, rather than individual 
research participants. Populations include ethnic groups, residents of 
a specific geographical location, an identifiable group either affected 
by or susceptible to some health condition, a virtual community 
sharing a common interest and connected on the internet, etc. 
The guidelines do mention research on populations, but their main 
concern is individual research participants, as is evident in their 
numerous entries on consent.
Throughout the document ‘consent’ applies only to individuals. 
In guideline 7 on ‘Community engagement’, there is no mention of 
community consent for research, although the co-operation of the 
community is usually very important, if not essential, for research to 
proceed. Moreover, RECs need to decide whether researchers have to 
give the community an opportunity to consent to the dissemination 
of the results of the research as a condition for their agreement to 
participate in a study.
Three new guidelines deal with problematic aspects of consent 
that arise in public-health research. The very lengthy guideline 
20, ‘Research in disasters and disease outbreaks’, requires that ‘the 
individual informed consent of participants is obtained even in a 
situation of duress, unless the conditions for a waiver of informed 
consent are met’. The last of these conditions from guideline 10 – that 
the research would not be feasible or practicable to carry out without 
the waiver or modification, the research has important social value, 
and the research poses no more than minimal risks to the participants 
– may be impossible to fulfil in disasters and epidemics. When there 
are entire populations affected by an earthquake or outbreak of 
infectious disease, different interventions can be implemented, 
and evaluated afterwards to determine which were more effective 
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in alleviating the health effects of the disaster. It would often be 
impossible to obtain individual consent from all those involved in the 
interventions.[10] 
Guideline 21, ‘Cluster randomised trials’, is more permissive in 
allowing exceptions to individual informed consent. The guideline 
authorises researchers, sponsors, relevant authorities and RECs to 
‘determine whether it is required or feasible to obtain informed 
consent from patients, healthcare workers, or community members 
in certain studies’ and to ‘determine whether requiring informed 
consent and allowing refusal to consent may invalidate or compromise 
the research results’. However, the commentary on the guideline 
withdraws this discretion from researchers, and stipulates that for 
such research, a waiver or modification of consent must be obtained 
from a REC. 
Guideline 22, ‘Use of data obtained from the online environment 
and digital tools in health-related research’, deals mostly with privacy. 
Where it does mention consent it reverts to what seems to be a 
requirement for individual consent to use online personal health-
related data: ‘Researchers should inform persons whose data may 
be used in the context of research in the online environment of: the 
purpose and context of intended uses of data and information; the 
privacy and security measures used to protect their data, and any 
related privacy risks; and the limitations of the measures used and 
the privacy risks that may remain despite the safeguards put in place’. 
Although this statement uses ‘should’ rather than ‘must’, it is arguably 
too restrictive. Much public-health data, including official statistical 
reports, can be obtained from conventional media sources such as 
newspapers and the internet. Even though the data may identify 
individuals or communities, there should generally be no need to 
obtain their consent. Whether this applies to data from so-called 
social media (Facebook, Twitter, etc.) is unanswered in the guidelines. 
Community involvement
Although the new guideline 7 deals explicitly with this topic, it 
leaves several questions unasked. How can researchers, especially 
those from outside, gain the trust of the population, especially if the 
population has had negative experiences with previous researchers? 
If the researchers, or their assistants, are from within the population, 
how can they avoid a conflict of interest between the requirements of 
the research and the needs or desires of population members? Who 
owns the results – the researchers or the population, or both? Does 
the population have a right to participate in the interpretation of the 
data? Can it veto the dissemination of results that could stigmatise it? 
A REC needs to be assured that the researchers have considered these 
issues and have a sound plan to deal with them before the project is 
approved.
Dissemination of research results
Guideline 24, ‘Public accountability for health-related research’, 
requires researchers to ‘prospectively register their studies, publish 
the results and share the data on which these results are based in a 
timely manner’. The commentary on this guideline states: ‘Researchers 
and sponsors have an obligation to register their studies before they 
actually start’. As desirable as this may be, it is not feasible for most 
public-health research. There is no public-health research equivalent 
of the various clinical-trial registries where proposed studies can be 
listed and, in some cases, their results can be summarised.  
Conclusion
Public-health researchers can be pleased that CIOMS has recognised 
that the ethics of research applies to their field just as much 
as to other types of health-related research. They will likely be 
concerned, however, that the differences between their needs and 
those of other health researchers are not sufficiently accounted 
for in the revised guidelines. This is understandable, considering 
the relative underdevelopment of public-health research ethics 
compared with other health-research ethics, which benefits from a 
huge literature and multiple international and national guidelines 
and regulations. One can hope that the new CIOMS guidelines will 
spur all those involved in public-health research ethics to intensify 
their efforts to develop both the theoretical foundations and the 
practical applications of this field, so that the next revision of the 
guidelines, and of other international and national research ethics 
documents, will be as useful for public-health research as for all other 
health research.
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